ONCOZ
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
OncoZenge is a Swedish pharmaceutical company that develops treatments for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. The company's product candidate is undergoing further development after completing phase 2 studies to form the basis for application for regulatory market approvals and commercialization. OncoZenge is headquartered in Bromma.
Read moreRevenue M
EBIT-% (adj.)
EPS (adj.)
Dividend %
Interim report Q3'26
Annual report '26
Interim report Q1'27
Don't miss out - create an account and get all the possible benefits